Sintx Technologies logo
Sintx Technologies SINT
$ 2.56 -0.39%

Annual report 2025
added 03-20-2026

report update icon

Sintx Technologies Income Statement 2011-2026 | SINT

Annual Income Statement Sintx Technologies

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

6.91 M 1.85 M 187 K 679 K 123 K 29.5 M 3.21 M 2.24 M 9.95 M 587 K 1.01 M 685 K - - -

Shares

2.77 M 741 K 3.74 M 302 K 247 K 16.4 M 1.56 M 365 K 99.3 K 51.5 K 12.1 K 2.27 K - - -

Historical Prices

2.49 2.49 0.05 2.25 0.5 1.8 1.84 6.3 99.5 11.2 83.7 302 - - -

Net Income

-10.4 M -11 M -8.26 M -12 M -9.31 M -7.03 M -4.8 M -8.65 M -9.33 M -16.6 M -23.9 M -32.6 M -8.29 M -35 M -23.8 M

Revenue

1.02 M 2.89 M 2.63 M 1.56 M 606 K 594 K 689 K 95 K 11.2 M 15.2 M 19.5 M 22.8 M 22.3 M 23.1 M 20.3 M

Cost of Revenue

557 K 811 K 784 K 265 K 449 K 475 K 551 K 56 K 6.35 M 3.78 M 6.25 M 7.91 M 7.04 M - -

Gross Profit

461 K 2.08 M 1.84 M 1.3 M 157 K 119 K 138 K 39 K 4.88 M 11.4 M 13.2 M 14.9 M 15.3 M 16.6 M 16.2 M

Operating Income

-10.7 M -14 M -13.4 M -11.3 M -10.6 M -8.5 M -6.59 M -13.1 M -7.48 M -11.5 M -12 M -24.2 M -10.3 M - -

Interest Expense

31 K 39 K 17 K 382 K 4 K 282 K 48 K 83 K - - -14 K 3.65 M 1.85 M - -

EBITDA

-10.4 M -13.2 M -12.5 M -11 M -10.4 M -9.25 M -6.12 M -6.84 M -9.94 M -9.6 M -9.89 M -21.8 M -8.13 M -9.56 M -10.3 M

Operating Expenses

11.2 M 16.1 M 15.2 M 12.6 M 10.8 M 9.87 M 6.73 M 6.99 M 15.9 M 23 M 25.2 M 39 M 25.6 M 30.4 M 32.2 M

General and Administrative Expenses

6.2 M 4 M 4.22 M 3.99 M 3.6 M 4.38 M 2.91 M 4.55 M 4.38 M 6.29 M 6.44 M 13.6 M 5.76 M 7.31 M 7.26 M

All numbers in USD currency

Quarterly Income Statement Sintx Technologies

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

2.96 M 2.54 M 1.77 M 1.34 M 896 K 631 K 86.3 K 26.6 K 21 K 20.4 K 2.27 M 542 K 24.7 M 247 K 247 K 24.7 M 24.7 M 24.7 M 24.7 M 24.6 M 22.8 M 12.1 M 6.02 M 2.43 M 2.13 M 932 K 726 K 726 K 419 K 195 K 3.41 M 3.03 M 3.02 M 3.02 M 2.83 M 2.28 M 1.92 M 12.8 M 11.2 M 907 K 4.58 M 3.62 M 1.8 M 1.76 M 12.7 M 12.4 M 5.97 M 598 K 572 K 533 K 418 K - - - - - - - -

Net Income

-3.54 M -2.32 M -2.29 M - -6.24 M -2.2 M -886 K - -3.19 M -2.46 M -293 K - -2.72 M -2.51 M -2.84 M - -2.34 M -2.2 M -2.63 M - -2.44 M -4.03 M 1.17 M - -1.45 M -730 K -1.63 M - -3.25 M -2.31 M -3.4 M - -2.07 M -1.7 M -512 K - -5.19 M -5.06 M -3.39 M - -10.1 M -5.93 M -5.38 M - -4.93 M -13.2 M -4.71 M - -2.35 M -3.07 M -3.53 M - - - - - - - -

Revenue

208 K 151 K 369 K - 799 K 859 K 687 K - 678 K 508 K 539 K - 426 K 240 K 129 K - 239 K 101 K 101 K - 66 K 204 K 207 K - 173 K 167 K 97 K - - 2.04 M 2.29 M - 2.96 M 3.21 M 2.63 M - 3.38 M 4.02 M 4.17 M - 4.84 M 4.78 M 4.74 M - 6 M 5.84 M 5.78 M - 5.3 M 6.05 M 5.25 M - - - - - - - -

Cost of Revenue

115 K 94 K 246 K - 210 K 224 K 223 K - 117 K 104 K 118 K - 89 K 66 K 80 K - 190 K 73 K 61 K - 53 K 163 K 166 K - 151 K 133 K 79 K - - 521 K 524 K - 1.41 M 722 K 661 K - 765 K 1.02 M 893 K - 1.64 M 1.36 M 1.52 M - 1.94 M 1.6 M 1.65 M - 1.74 M 1.33 M 1.95 M - - - - - - - -

Gross Profit

93 K 57 K 123 K - 589 K 635 K 464 K - 561 K 404 K 421 K - 337 K 174 K 49 K - 49 K 28 K 40 K - 13 K 41 K 41 K - 22 K 34 K 18 K - - 1.52 M 1.77 M - 1.55 M 2.49 M 1.97 M - 2.61 M 3.01 M 3.28 M - 3.2 M 3.42 M 3.22 M - 4.06 M 4.23 M 4.13 M - - - - - - - - - - - -

Operating Income

-3.36 M -2.66 M -2.38 M - -6.41 M -2.71 M -3.2 M - -3.61 M -3.46 M -3.56 M - -2.79 M -2.78 M -2.88 M - -2.82 M -2.36 M -2.84 M - -2.43 M -1.98 M -1.85 M - -1.7 M -1.52 M -1.73 M - -7.36 M -1.9 M -2.23 M - -1.97 M -1.72 M -1.8 M - -3.21 M -2.5 M -2.48 M - -2.81 M -2.6 M -4.01 M - -5.64 M -10.6 M -4.06 M - -2.02 M -2.67 M -2.77 M - - - - - - - -

Interest Expense

- 2 K 1 K - 1 K 27 K 6 K - - -3 K 8 K - 8 K 162 K - - -1 K 130 K 12 K - 200 K - - - 48 K 48 K - - 1 K 3 K 2 K - 1 K -4 K - - 5 K -1 K - - 1.15 M 1.13 M 1.1 M - 1.11 M 554 K 530 K - 453 K 445 K 447 K - - - - - - - -

EBITDA

- - -2.29 M - - - -2.94 M - - - -3.4 M - -2.56 M -2.65 M -2.81 M - -2.71 M -2.29 M -2.81 M - -2.33 M -1.95 M -1.84 M - -1.62 M -1.47 M -1.7 M - -7.29 M -1.85 M -2.2 M - -1.97 M -1.43 M -1.64 M - -2.08 M -1.73 M -2.1 M - -1.54 M -1.76 M -3.58 M - -4.27 M -9.73 M -3.62 M - -728 K -1.78 M -2.26 M - - - - - - - -

Operating Expenses

3.45 M 2.72 M 2.51 M - 7 M 3.34 M 3.66 M - 4.18 M 3.87 M 3.98 M - 3.13 M 2.96 M 2.93 M - 2.87 M 2.39 M 2.88 M - 2.44 M 2.02 M 1.9 M - 1.72 M 1.56 M 1.75 M - 7.36 M 1.9 M 2.23 M - 1.97 M 4.21 M 3.77 M - 5.82 M 5.51 M 5.76 M - 6 M 6.01 M 7.23 M - 9.7 M 14.9 M 8.19 M - 5.58 M 7.4 M 6.08 M - - - - - - - -

General and Administrative Expenses

2.1 M 1.31 M 1.16 M - 802 K 1.07 M 1.12 M - 990 K 1.17 M 1.17 M - 1.07 M 993 K 856 K - 933 K 858 K 1 M - 827 K 826 K 764 K - 714 K 615 K 971 K - 654 K 935 K 1.31 M - 901 K 1.08 M 1.11 M - 1.91 M 1.36 M 1.56 M - 1.43 M 1.33 M 2.03 M - 2.94 M 6.28 M 3.08 M - 1.19 M 1.49 M 1.38 M - - - - - - - -

All numbers in USD currency

The income statement is one of the three key financial reports of a company Sintx Technologies (alongside the balance sheet and the cash flow statement). It shows how the company makes money and what its expenses are:

  • How much revenue the company earned
  • How much it spent on production, personnel, marketing, taxes, etc.
  • What profit remained in the end

Analyzing the income statement helps an investor understand whether the business generates stable and growing profits, how effectively the company controls its expenses, and whether it is capable of generating income in the future. Additionally, this analysis shows how the company copes with crises and economic cycles, and allows assessing the potential for stock price growth and dividend payments.

Features
  • The income statement may include both recurring and one-time items (for example, profit from the sale of assets). It is necessary to separate core metrics from one-off events for accurate analysis.
  • Companies often publish interim reports (e.g., quarterly), which allows for more timely tracking of trends.
  • A combined analysis of the income statement with the balance sheet and cash flow statement provides a comprehensive view of the company’s financial health.

Reports on the profits and losses of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
EDAP TMS S.A. EDAP TMS S.A.
EDAP
$ 3.71 -5.12 % $ 138 M franceFrance
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Profound Medical Corp. Profound Medical Corp.
PROF
$ 5.82 13.01 % $ 180 M canadaCanada
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Delcath Systems Delcath Systems
DCTH
$ 9.2 2.45 % $ 330 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 37.08 1.42 % $ 1.15 B usaUSA
Smith & Nephew plc Smith & Nephew plc
SNN
- - $ 23.8 B britainBritain
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Electromed Electromed
ELMD
$ 24.66 -0.16 % $ 208 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
$ 2.16 7.46 % $ 1.31 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Integra LifeSciences Holdings Corporation Integra LifeSciences Holdings Corporation
IART
$ 9.55 0.1 % $ 735 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Inogen Inogen
INGN
$ 6.42 1.58 % $ 171 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
$ 1.33 -1.85 % $ 21.5 M usaUSA
IRadimed Corporation IRadimed Corporation
IRMD
$ 101.78 0.8 % $ 1.29 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.67 -3.52 % $ 36.5 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.32 7.41 % $ 3.62 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 63.3 1.44 % $ 3.45 B britainBritain
InspireMD InspireMD
NSPR
$ 1.77 -1.12 % $ 114 M israelIsrael
LENSAR LENSAR
LNSR
$ 5.58 0.36 % $ 64.3 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.39 -0.78 % $ 1.54 B usaUSA
Penumbra Penumbra
PEN
$ 336.27 0.63 % $ 13.1 B usaUSA
Medtronic PLC Medtronic PLC
MDT
$ 87.89 1.51 % $ 113 B usaUSA
MiMedx Group MiMedx Group
MDXG
$ 4.1 -0.73 % $ 606 M usaUSA
Nano-X Imaging Ltd. Nano-X Imaging Ltd.
NNOX
$ 2.29 -4.58 % $ 134 M israelIsrael
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 16.23 2.01 % $ 381 M usaUSA
Myomo Myomo
MYO
$ 0.7 -0.1 % $ 29.3 M usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 51.41 -1.27 % $ 1.51 B usaUSA
Orthofix Medical Orthofix Medical
OFIX
$ 11.93 1.79 % $ 472 M curacaoCuracao